Arca Biopharma Stock Price on April 20, 2022
| ABIO Stock | USD 3.25 0.04 1.25% |
Below is the normalized historical share price chart for ARCA Biopharma extending back to August 08, 1997. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of ARCA Biopharma stands at 3.25, as last reported on the 19th of April, with the highest price reaching 3.32 and the lowest price hitting 3.13 during the day.
If you're considering investing in ARCA Stock, it is important to understand the factors that can impact its price. ARCA Biopharma is dangerous given 3 months investment horizon. ARCA Biopharma retains Efficiency (Sharpe Ratio) of 0.13, which signifies that the company had a 0.13% return per unit of risk over the last 3 months. We were able to collect and analyze data for thirty different technical indicators, which can help you to evaluate if expected returns of 1.54% are justified by taking the suggested risk. Use ARCA Biopharma market risk adjusted performance of 0.9506, and Coefficient Of Variation of 762.18 to evaluate company specific risk that cannot be diversified away.
At this time, ARCA Biopharma's Common Stock Shares Outstanding is very stable compared to the past year. As of the 19th of April 2024, Sale Purchase Of Stock is likely to grow to about 59 M, while Total Stockholder Equity is likely to drop about 22.4 M. . As of the 19th of April 2024, Price To Sales Ratio is likely to drop to 0.26. In addition to that, Price Earnings Ratio is likely to drop to -4.82. ARCA Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 8th of August 1997 | 200 Day MA 1.9294 | 50 Day MA 2.005 | Beta 1.205 |
ARCA |
Sharpe Ratio = 0.1343
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ABIO | |||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 11.49 actual daily | 96 96% of assets are less volatile |
Expected Return
| 1.54 actual daily | 30 70% of assets have higher returns |
Risk-Adjusted Return
| 0.13 actual daily | 10 90% of assets perform better |
Based on monthly moving average ARCA Biopharma is performing at about 10% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of ARCA Biopharma by adding it to a well-diversified portfolio.
Price Book 1.2691 | Book Value 2.553 | Enterprise Value 10 M | Enterprise Value Ebitda (1.36) | Shares Float 6.7 M |
ARCA Biopharma Valuation on April 20, 2022
It is possible to determine the worth of ARCA Biopharma on a given historical date. On April 20, 2022 ARCA was worth 2.41 at the beginning of the trading date compared to the closed value of 2.46. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of ARCA Biopharma stock. Still, in general, we apply an absolute valuation method to find ARCA Biopharma's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of ARCA Biopharma where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against ARCA Biopharma's related companies.
| Open | High | Low | Close | Volume | |
| 2.38 | 2.44 | 2.32 | 2.42 | 137,884 | |
04/20/2022 | 2.41 | 2.59 | 2.34 | 2.46 | 370,543 |
| 2.41 | 2.48 | 2.40 | 2.41 | 106,199 |
| Backtest ARCA Biopharma | | | ARCA Biopharma History | | | ARCA Biopharma Valuation | Previous | Next |
ARCA Biopharma Trading Date Momentum on April 20, 2022
| On April 21 2022 ARCA Biopharma was traded for 2.41 at the closing time. The top price for the day was 2.48 and the lowest listed price was 2.40 . The trading volume for the day was 106.2 K. The trading history from April 21, 2022 was a factor to the next trading day price decrease. The overall trading delta against the next closing price was 2.03% . The overall trading delta against the current closing price is 3.25% . |
ARCA Biopharma Fundamentals Correlations and Trends
By evaluating ARCA Biopharma's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among ARCA Biopharma's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. ARCA financial account trend analysis is a perfect complement when working with valuation or volatility modules.About ARCA Biopharma Stock history
ARCA Biopharma investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for ARCA is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in ARCA Biopharma will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing ARCA Biopharma stock prices may prove useful in developing a viable investing in ARCA Biopharma
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 14.4 M | 15.1 M | |
| Net Loss | -8.9 M | -9.4 M |
ARCA Biopharma Quarterly Net Working Capital |
|
ARCA Biopharma Stock Technical Analysis
ARCA Biopharma technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
ARCA Biopharma Period Price Range
Low | April 20, 2022
| High |
2.41 | 2.46 |
ARCA Biopharma April 19, 2024 Market Strength
Market strength indicators help investors to evaluate how ARCA Biopharma stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading ARCA Biopharma shares will generate the highest return on investment. By undertsting and applying ARCA Biopharma stock market strength indicators, traders can identify ARCA Biopharma entry and exit signals to maximize returns
ARCA Biopharma Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for ARCA Biopharma's price direction in advance. Along with the technical and fundamental analysis of ARCA Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of ARCA to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0905 | |||
| Jensen Alpha | 1.37 | |||
| Total Risk Alpha | 0.3985 | |||
| Sortino Ratio | 0.6817 | |||
| Treynor Ratio | 0.9406 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in ARCA Biopharma. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product. To learn how to invest in ARCA Stock, please use our How to Invest in ARCA Biopharma guide.You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Complementary Tools for ARCA Stock analysis
When running ARCA Biopharma's price analysis, check to measure ARCA Biopharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ARCA Biopharma is operating at the current time. Most of ARCA Biopharma's value examination focuses on studying past and present price action to predict the probability of ARCA Biopharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ARCA Biopharma's price. Additionally, you may evaluate how the addition of ARCA Biopharma to your portfolios can decrease your overall portfolio volatility.
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Stocks Directory Find actively traded stocks across global markets | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data |
Is ARCA Biopharma's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ARCA Biopharma. If investors know ARCA will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ARCA Biopharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.37) | Return On Assets (0.11) | Return On Equity (0.14) |
The market value of ARCA Biopharma is measured differently than its book value, which is the value of ARCA that is recorded on the company's balance sheet. Investors also form their own opinion of ARCA Biopharma's value that differs from its market value or its book value, called intrinsic value, which is ARCA Biopharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ARCA Biopharma's market value can be influenced by many factors that don't directly affect ARCA Biopharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ARCA Biopharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if ARCA Biopharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ARCA Biopharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.